Pure Global

REACTIVO PARA DETERMINACIÓN DE BENZOILECGONINA (METABOLITO DE COCAÍNA) - COFEPRIS Registration 0638R2022 SSA

Access comprehensive regulatory information for REACTIVO PARA DETERMINACIÓN DE BENZOILECGONINA (METABOLITO DE COCAÍNA) (REACTIVO PARA DETERMINACIÓN DE BENZOILECGONINA (METABOLITO DE COCAÍNA)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0638R2022 SSA and manufactured by BECKMAN COULTER DE MÉXICO, S.A. DE C.V.. The device was registered on July 20, 2022.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase I
0638R2022 SSA
REACTIVO PARA DETERMINACIÓN DE BENZOILECGONINA (METABOLITO DE COCAÍNA)
COFEPRIS Analysis ID: 0638R2022 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase I
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
EMIT® II PLUS COCAINE METABOLITE ASSAY
Trade Name (English)
EMIT® II PLUS COCAINE METABOLITE ASSAY
Registration Information
Analysis ID
0638R2022 SSA
Registration Date
July 20, 2022
Manufacturer / Fabricante
Name (English)
BECKMAN COULTER DE MÉXICO, S.A. DE C.V.